78 related articles for article (PubMed ID: 25001862)
1. The antiviral immune response in human conventional dendritic cells is controlled by the mammalian target of rapamycin.
Fekete T; Pazmandi K; Szabo A; Bacsi A; Koncz G; Rajnavölgyi E
J Leukoc Biol; 2014 Oct; 96(4):579-89. PubMed ID: 25001862
[TBL] [Abstract][Full Text] [Related]
2. Regulation of RLR-Mediated Antiviral Responses of Human Dendritic Cells by mTOR.
Fekete T; Ágics B; Bencze D; Bene K; Szántó A; Tarr T; Veréb Z; Bácsi A; Pázmándi K
Front Immunol; 2020; 11():572960. PubMed ID: 33013932
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway.
Cao W; Manicassamy S; Tang H; Kasturi SP; Pirani A; Murthy N; Pulendran B
Nat Immunol; 2008 Oct; 9(10):1157-64. PubMed ID: 18758466
[TBL] [Abstract][Full Text] [Related]
4. Interferon gamma boosts the nucleotide oligomerization domain 2-mediated signaling pathway in human dendritic cells in an X-linked inhibitor of apoptosis protein and mammalian target of rapamycin-dependent manner.
Fekete T; Koncz G; Szabo B; Gregus A; Rajnavölgyi E
Cell Mol Immunol; 2017 Apr; 14(4):380-391. PubMed ID: 26521691
[TBL] [Abstract][Full Text] [Related]
5. Regulatory NLRs Control the RLR-Mediated Type I Interferon and Inflammatory Responses in Human Dendritic Cells.
Fekete T; Bencze D; Szabo A; Csoma E; Biro T; Bacsi A; Pazmandi K
Front Immunol; 2018; 9():2314. PubMed ID: 30344524
[TBL] [Abstract][Full Text] [Related]
6. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum.
Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA
Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948
[TBL] [Abstract][Full Text] [Related]
7. Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation.
Kuo CH; Hsieh CC; Kuo HF; Huang MY; Yang SN; Chen LC; Huang SK; Hung CH
Allergy; 2013 Jul; 68(7):870-9. PubMed ID: 23738920
[TBL] [Abstract][Full Text] [Related]
8. RLR-mediated production of interferon-β by a human dendritic cell subset and its role in virus-specific immunity.
Szabo A; Bene K; Gogolák P; Réthi B; Lányi Á; Jankovich I; Dezső B; Rajnavölgyi E
J Leukoc Biol; 2012 Jul; 92(1):159-69. PubMed ID: 22517920
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor-induced c-Src-phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway inhibits dendritic cell activation by blocking IκB kinase activity.
Singhal E; Sen P
Int J Biochem Cell Biol; 2011 Aug; 43(8):1134-46. PubMed ID: 21536148
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin and omega-1: mTOR-dependent and -independent Th2 skewing by human dendritic cells.
Hussaarts L; Smits HH; Schramm G; van der Ham AJ; van der Zon GC; Haas H; Guigas B; Yazdanbakhsh M
Immunol Cell Biol; 2013 Aug; 91(7):486-9. PubMed ID: 23835553
[TBL] [Abstract][Full Text] [Related]
11. Human CD34-derived myeloid dendritic cell development requires intact phosphatidylinositol 3-kinase-protein kinase B-mammalian target of rapamycin signaling.
van de Laar L; Buitenhuis M; Wensveen FM; Janssen HL; Coffer PJ; Woltman AM
J Immunol; 2010 Jun; 184(12):6600-11. PubMed ID: 20488790
[TBL] [Abstract][Full Text] [Related]
12. A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation.
Haidinger M; Poglitsch M; Geyeregger R; Kasturi S; Zeyda M; Zlabinger GJ; Pulendran B; Hörl WH; Säemann MD; Weichhart T
J Immunol; 2010 Oct; 185(7):3919-31. PubMed ID: 20805416
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Effects of Interferon-γ and Vitamin D
Švajger U; Rožman PJ
Front Immunol; 2019; 10():2627. PubMed ID: 31798578
[TBL] [Abstract][Full Text] [Related]
15. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
Bohnenkamp HR; Papazisis KT; Burchell JM; Taylor-Papadimitriou J
Cell Immunol; 2007 Jun; 247(2):72-84. PubMed ID: 17927969
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide signaling activates dendritic cell-mediated type 1 immune responses through neurokinin-2 receptor.
Kitamura H; Kobayashi M; Wakita D; Nishimura T
J Immunol; 2012 May; 188(9):4200-8. PubMed ID: 22474018
[TBL] [Abstract][Full Text] [Related]
17. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.
Sekulić A; Hudson CC; Homme JL; Yin P; Otterness DM; Karnitz LM; Abraham RT
Cancer Res; 2000 Jul; 60(13):3504-13. PubMed ID: 10910062
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
19. Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons.
Kunzmann V; Kretzschmar E; Herrmann T; Wilhelm M
Immunology; 2004 Jul; 112(3):369-77. PubMed ID: 15196204
[TBL] [Abstract][Full Text] [Related]
20. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.
Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY
Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
